nodes	percent_of_prediction	percent_of_DWPC	metapath
Ximelagatran—F2—posterior vena cava—kidney cancer	0.354	0.673	CbGeAlD
Ximelagatran—CYP2C9—Capecitabine—kidney cancer	0.163	0.458	CbGbCtD
Ximelagatran—CYP2C9—Paclitaxel—kidney cancer	0.102	0.287	CbGbCtD
Ximelagatran—F2—urine—kidney cancer	0.0914	0.174	CbGeAlD
Ximelagatran—CYP2C9—Sorafenib—kidney cancer	0.0908	0.255	CbGbCtD
Ximelagatran—CYP2C9—urine—kidney cancer	0.0364	0.0693	CbGeAlD
Ximelagatran—F2—renal system—kidney cancer	0.0224	0.0426	CbGeAlD
Ximelagatran—F2—kidney—kidney cancer	0.0216	0.0411	CbGeAlD
Ximelagatran—F2—FOXA2 and FOXA3 transcription factor networks—HNF1A—kidney cancer	0.00553	0.0467	CbGpPWpGaD
Ximelagatran—F2—PAR1-mediated thrombin signaling events—AKAP13—kidney cancer	0.00427	0.0361	CbGpPWpGaD
Ximelagatran—F2—Regulation of IGF Activity by IGFBP—IGF2—kidney cancer	0.00396	0.0335	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—L1CAM—kidney cancer	0.00366	0.0309	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—GRB7—kidney cancer	0.00346	0.0292	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—kidney cancer	0.00318	0.0269	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—SCARB1—kidney cancer	0.00273	0.0231	CbGpPWpGaD
Ximelagatran—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—kidney cancer	0.00249	0.021	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—PAK1—kidney cancer	0.00242	0.0204	CbGpPWpGaD
Ximelagatran—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—kidney cancer	0.00227	0.0192	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—SCARB1—kidney cancer	0.00222	0.0188	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—GRB7—kidney cancer	0.002	0.0169	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—SOD2—kidney cancer	0.00185	0.0156	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—SCARB1—kidney cancer	0.00177	0.0149	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—PTGS1—kidney cancer	0.00175	0.0148	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—SOD2—kidney cancer	0.0015	0.0127	CbGpPWpGaD
Ximelagatran—F2—Post-translational protein modification—MUC4—kidney cancer	0.0014	0.0118	CbGpPWpGaD
Ximelagatran—F2—Post-translational protein modification—ST3GAL2—kidney cancer	0.00133	0.0112	CbGpPWpGaD
Ximelagatran—CYP2C9—Xenobiotics—CYP1A1—kidney cancer	0.0012	0.0101	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—SOD2—kidney cancer	0.00119	0.0101	CbGpPWpGaD
Ximelagatran—F2—IL1 and megakaryotyces in obesity—PIK3CA—kidney cancer	0.00117	0.00985	CbGpPWpGaD
Ximelagatran—CYP2C9—Tamoxifen metabolism—CYP1A1—kidney cancer	0.00115	0.00973	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.00114	0.00959	CbGpPWpGaD
Ximelagatran—F2—Thrombin signalling through proteinase activated receptors (PARs)—MAPK3—kidney cancer	0.00112	0.00947	CbGpPWpGaD
Ximelagatran—F2—G alpha (q) signalling events—ITPR2—kidney cancer	0.00112	0.00946	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—ACY1—kidney cancer	0.0011	0.0093	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—RELA—kidney cancer	0.00108	0.00916	CbGpPWpGaD
Ximelagatran—F2—Thrombin signalling through proteinase activated receptors (PARs)—MAPK1—kidney cancer	0.00107	0.00901	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—RELA—kidney cancer	0.00107	0.00901	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—PAK1—kidney cancer	0.00101	0.00853	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR2—kidney cancer	0.001	0.00846	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—L1CAM—kidney cancer	0.000991	0.00837	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—ITPR2—kidney cancer	0.000979	0.00827	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—EIF5B—kidney cancer	0.000956	0.00808	CbGpPWpGaD
Ximelagatran—F2—G alpha (q) signalling events—ANXA1—kidney cancer	0.000938	0.00793	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—ANXA1—kidney cancer	0.000926	0.00783	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—OR4C13—kidney cancer	0.000904	0.00763	CbGpPWpGaD
Ximelagatran—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	0.000893	0.00755	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonic acid metabolism—PTGS1—kidney cancer	0.000892	0.00754	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—RELA—kidney cancer	0.000868	0.00733	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—CUL7—kidney cancer	0.000852	0.0072	CbGpPWpGaD
Ximelagatran—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	0.000851	0.00719	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—ANXA1—kidney cancer	0.000839	0.00709	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—OR4C13—kidney cancer	0.000821	0.00693	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—HSPA9—kidney cancer	0.000813	0.00687	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—MAPK3—kidney cancer	0.000785	0.00663	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—IL2—kidney cancer	0.000782	0.0066	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—ANXA2—kidney cancer	0.000751	0.00635	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—MAPK1—kidney cancer	0.000747	0.00631	CbGpPWpGaD
Ximelagatran—F2—PAR1-mediated thrombin signaling events—PIK3CA—kidney cancer	0.000731	0.00618	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—RELA—kidney cancer	0.000689	0.00583	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—PTGS2—kidney cancer	0.00067	0.00566	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—MUC4—kidney cancer	0.000663	0.0056	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—kidney cancer	0.000648	0.00547	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—ST3GAL2—kidney cancer	0.000631	0.00533	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000625	0.00528	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—KCNMA1—kidney cancer	0.000622	0.00526	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—ANXA1—kidney cancer	0.000621	0.00525	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—EEF2—kidney cancer	0.000616	0.00521	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—ALDH1A1—kidney cancer	0.000603	0.0051	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—IGF2—kidney cancer	0.000602	0.00509	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—APC—kidney cancer	0.000579	0.00489	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonic acid metabolism—CYP1A1—kidney cancer	0.000575	0.00486	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—BRAF—kidney cancer	0.000544	0.0046	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—GRB7—kidney cancer	0.000543	0.00459	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—ITPR2—kidney cancer	0.000505	0.00427	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—TP53—kidney cancer	0.000502	0.00424	CbGpPWpGaD
Ximelagatran—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000497	0.0042	CbGpPWpGaD
Ximelagatran—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000491	0.00414	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—OR4C13—kidney cancer	0.000485	0.0041	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—ANXA1—kidney cancer	0.000473	0.004	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—MME—kidney cancer	0.000472	0.00399	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—RAF1—kidney cancer	0.000454	0.00384	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—POMC—kidney cancer	0.000454	0.00383	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—RPL14—kidney cancer	0.000439	0.00371	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—HSPD1—kidney cancer	0.000439	0.00371	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—LATS1—kidney cancer	0.000412	0.00348	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—KRAS—kidney cancer	0.000408	0.00345	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000403	0.0034	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—AKAP13—kidney cancer	0.000375	0.00317	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—PIK3CA—kidney cancer	0.000375	0.00317	CbGpPWpGaD
Ximelagatran—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000371	0.00313	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—IFNA1—kidney cancer	0.000371	0.00313	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—ACHE—kidney cancer	0.000362	0.00306	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—EIF4EBP1—kidney cancer	0.000358	0.00302	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—GSTT1—kidney cancer	0.000354	0.00299	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—AMER1—kidney cancer	0.00035	0.00296	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—IFNA2—kidney cancer	0.000345	0.00291	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—PAX6—kidney cancer	0.000345	0.00291	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—CTSD—kidney cancer	0.000343	0.0029	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonic acid metabolism—PTGS2—kidney cancer	0.000342	0.00289	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—AKAP13—kidney cancer	0.000341	0.00288	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—kidney cancer	0.000339	0.00286	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—PTGS1—kidney cancer	0.000332	0.00281	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—RAF1—kidney cancer	0.000332	0.0028	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—MAPK3—kidney cancer	0.000328	0.00277	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—ITPR2—kidney cancer	0.000319	0.0027	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—BCHE—kidney cancer	0.000315	0.00267	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—MAPK1—kidney cancer	0.000312	0.00263	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—IGF2—kidney cancer	0.000311	0.00262	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	0.000304	0.00257	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.0003	0.00254	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—IL2—kidney cancer	0.000297	0.00251	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—KRAS—kidney cancer	0.000294	0.00249	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GPC3—kidney cancer	0.000294	0.00248	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CER1—kidney cancer	0.000294	0.00248	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000293	0.00248	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—ITPR2—kidney cancer	0.00029	0.00245	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—PIK3CA—kidney cancer	0.00027	0.00229	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—ANXA1—kidney cancer	0.000267	0.00226	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	0.000253	0.00213	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SFRP2—kidney cancer	0.00025	0.00211	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—GSTP1—kidney cancer	0.000246	0.00208	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—kidney cancer	0.000244	0.00206	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—IGF2—kidney cancer	0.000244	0.00206	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—ANXA1—kidney cancer	0.000243	0.00205	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—GSTP1—kidney cancer	0.000242	0.00205	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	0.000239	0.00202	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—kidney cancer	0.000232	0.00196	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—POMC—kidney cancer	0.000232	0.00196	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	0.000227	0.00192	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—GSTM1—kidney cancer	0.000226	0.00191	CbGpPWpGaD
Ximelagatran—F2—G alpha (q) signalling events—PIK3CA—kidney cancer	0.000226	0.00191	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—GSTM1—kidney cancer	0.000223	0.00188	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	0.00022	0.00185	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—CYP1A1—kidney cancer	0.000214	0.00181	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—CYP1A1—kidney cancer	0.000211	0.00178	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	0.000202	0.0017	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—AKAP13—kidney cancer	0.000201	0.0017	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CASP2—kidney cancer	0.000201	0.0017	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	0.000197	0.00167	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ACY1—kidney cancer	0.000188	0.00159	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GRB7—kidney cancer	0.000184	0.00156	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ITPR2—kidney cancer	0.000171	0.00145	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—RAF1—kidney cancer	0.000171	0.00144	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—POMC—kidney cancer	0.000163	0.00138	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	0.000161	0.00136	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PDHB—kidney cancer	0.00016	0.00135	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—POMC—kidney cancer	0.00016	0.00135	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CTNNA1—kidney cancer	0.000155	0.00131	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—EIF4EBP1—kidney cancer	0.000154	0.0013	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HSPB1—kidney cancer	0.000154	0.0013	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—IL2—kidney cancer	0.000153	0.00129	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CCBL1—kidney cancer	0.000151	0.00127	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ANXA1—kidney cancer	0.000143	0.00121	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PSMD7—kidney cancer	0.000143	0.00121	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TSC1—kidney cancer	0.000143	0.00121	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—FLT1—kidney cancer	0.000139	0.00117	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	0.000136	0.00115	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—POMC—kidney cancer	0.000131	0.00111	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GLIPR1—kidney cancer	0.000131	0.0011	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PPAT—kidney cancer	0.000131	0.0011	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—VEGFA—kidney cancer	0.00013	0.0011	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	0.000129	0.00109	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—JUNB—kidney cancer	0.000129	0.00109	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PAK1—kidney cancer	0.000129	0.00109	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	0.000128	0.00108	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—MAPK3—kidney cancer	0.000123	0.00104	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—FH—kidney cancer	0.000121	0.00103	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—APRT—kidney cancer	0.000121	0.00103	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—POMC—kidney cancer	0.000119	0.001	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	0.000119	0.001	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—MAPK1—kidney cancer	0.000117	0.00099	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—CTNNB1—kidney cancer	0.000116	0.000983	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GPC3—kidney cancer	0.000114	0.000964	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CA2—kidney cancer	0.000111	0.000938	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—KRAS—kidney cancer	0.000111	0.000935	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ALAD—kidney cancer	0.000108	0.000914	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ST3GAL2—kidney cancer	0.000106	0.000892	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IGF2—kidney cancer	0.000105	0.000889	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CDKN2B—kidney cancer	0.000105	0.000885	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ALDH1A1—kidney cancer	0.000103	0.000872	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IGF1R—kidney cancer	0.000102	0.00086	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PIK3CA—kidney cancer	0.000102	0.000859	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PGK1—kidney cancer	9.89e-05	0.000836	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SLC5A3—kidney cancer	9.89e-05	0.000836	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—TP53—kidney cancer	9.84e-05	0.000831	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—RAF1—kidney cancer	9.81e-05	0.000829	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—LDHB—kidney cancer	9.7e-05	0.000819	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—IL2—kidney cancer	9.68e-05	0.000818	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—IL2—kidney cancer	8.79e-05	0.000743	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CA9—kidney cancer	8.41e-05	0.00071	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HIF1A—kidney cancer	8.38e-05	0.000708	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TSC2—kidney cancer	8.36e-05	0.000706	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	8.22e-05	0.000694	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—KDR—kidney cancer	8.01e-05	0.000677	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—APC—kidney cancer	7.38e-05	0.000624	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—KIT—kidney cancer	7.38e-05	0.000624	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CRABP1—kidney cancer	7.15e-05	0.000604	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—MAPK3—kidney cancer	7.07e-05	0.000597	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—POMC—kidney cancer	7.03e-05	0.000594	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—BRAF—kidney cancer	6.94e-05	0.000586	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—MAPK1—kidney cancer	6.73e-05	0.000568	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ITPR2—kidney cancer	6.65e-05	0.000562	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PIK3CA—kidney cancer	6.43e-05	0.000543	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—KRAS—kidney cancer	6.35e-05	0.000537	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	6.13e-05	0.000518	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTT1—kidney cancer	6.06e-05	0.000512	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ACHE—kidney cancer	6.06e-05	0.000512	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PIK3CA—kidney cancer	5.84e-05	0.000493	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—RAF1—kidney cancer	5.79e-05	0.000489	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—RELA—kidney cancer	5.77e-05	0.000487	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SCARB1—kidney cancer	5.74e-05	0.000485	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ERBB2—kidney cancer	5.73e-05	0.000484	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PTGS1—kidney cancer	5.68e-05	0.00048	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MTOR—kidney cancer	5.66e-05	0.000478	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PSMD7—kidney cancer	5.57e-05	0.000471	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CDKN1B—kidney cancer	5.31e-05	0.000448	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—BCHE—kidney cancer	5.28e-05	0.000446	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SLC5A5—kidney cancer	5.22e-05	0.000441	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IL2—kidney cancer	5.19e-05	0.000439	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCND1—kidney cancer	5.06e-05	0.000428	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—JUN—kidney cancer	5.05e-05	0.000427	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SLC2A1—kidney cancer	5.04e-05	0.000426	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CTNNB1—kidney cancer	5.01e-05	0.000424	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.89e-05	0.000413	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PTEN—kidney cancer	4.89e-05	0.000413	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—VEGFA—kidney cancer	4.41e-05	0.000373	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.26e-05	0.00036	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTP1—kidney cancer	4.2e-05	0.000355	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MAPK3—kidney cancer	4.18e-05	0.000353	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MYC—kidney cancer	4.06e-05	0.000343	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ABCB1—kidney cancer	3.98e-05	0.000336	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MAPK1—kidney cancer	3.97e-05	0.000336	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTM1—kidney cancer	3.86e-05	0.000326	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—KRAS—kidney cancer	3.75e-05	0.000317	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP1A1—kidney cancer	3.66e-05	0.000309	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PIK3CA—kidney cancer	3.45e-05	0.000291	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TP53—kidney cancer	3.34e-05	0.000282	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.01e-05	0.000254	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—POMC—kidney cancer	2.73e-05	0.000231	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PTGS2—kidney cancer	2.18e-05	0.000184	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PTEN—kidney cancer	1.9e-05	0.00016	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.34e-05	0.000113	CbGpPWpGaD
